QPT — Quest PharmaTech Cashflow Statement
0.000.00%
Last trade - 00:00- CA$4.23m
- CA$4.51m
Annual cashflow statement for Quest PharmaTech, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.3 | 190 | -85 | -7.33 | -3.02 |
| Depreciation | |||||
| Non-Cash Items | 1.11 | -186 | 84.7 | 6.99 | 2.42 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.75 | -6.61 | 0.082 | -0.225 | 0.249 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.38 | -2.52 | -0.171 | -0.555 | -0.342 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.78 | 0.262 | -0.014 | -0.014 | 0 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2.78 | 0.262 | -0.014 | -0.014 | 0 |
| Financing Cash Flow Items | 0 | — | — | — | 0.685 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.4 | 0.299 | 0.25 | 0.679 | 0.685 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.81 | -1.95 | 0.065 | 0.11 | 0.342 |